Abstract:Objective:To compare the imaging features of renal cell carcinoma (RCC) associated with Xp11.2 translocation/TFE3 gene fusion (Xp11.2 RCC) with chromophobe RCC.Methods:From November 2016 to January 2020, 28 patients with Xp11.2 RCC and 28 patients with chromophobe RCC confirmed by pathology were retrospectively analyzed in Peking University First Hospital. All 23 patients underwent preoperative CT examination, and 5 patients underwent routine MRI in each group. The clinical and imaging features were observed and recorded. The CT features including side, location, size, boundary, shape, uniform density, composition (solid, cystic-solid, cystic), hemorrhage, calcification, lymph node metastasis of the lesions and distant metastasis were observed, and the CT value of the solid part of the tumor at each stage was measured. On MRI images, the signal of the lesion in each sequence and enhancement mode were observed. The differences in clinical and imaging characteristics between the 2 groups were compared using independent samples t test or χ 2 test. Results:The Xp11.2 RCC more frequently affected young [(27±10) years] patients, while chromophobe RCC more frequently involved middle-aged [(37±7) years] patients asymptomatically, and the difference was statistically significant ( t=-4.99, P<0.001). The lesion size of Xp11.2 RCC [(5.4±2.2) cm] were significantly smaller than that of chromophobe RCC [(6.9±1.8) cm] ( t=-2.93, P=0.005). There were significant differences in the density and composition of lesions between Xp11.2 RCC and chromophobe RCC (χ 2=4.60, 18.67, P=0.032,<0.001). There were no significant differences in the side, location, boundary, shape, hemorrhage, calcification, fat, lymph node metastasis and distant metastasis between the 2 kind of lesions (all P>0.05). The CT values of solid components in Xp11.2 RCC in cortico-medullary phase and delayed phase were higher than those in chromophobe RCC, and the difference were statistically significant ( t=11.80, 20.15, both P<0.001). Five cases of Xp11.2 RCC showed iso- or slightly hyperintense signal on T 1WI and slightly hypointense signal on T 2WI. Two cases showed delayed enhancement after enhancement, and 3 cases showed a slight decrease in delayed phase enhancement. Conclusion:Compared with chromophobe RCC, Xp11.2 RCC has certain characteristics in imaging manifestations (lesion size, density uniformity, composition, CT value of post-enhanced cortico-medullary phase and delayed phase). Imaging manifestations combining the clinical manifestations (age of onset) are helpful for preoperative diagnosis of Xp11.2 RCC.

Molecular Heterogeneity of Xp11.2 Translocation Renal Cell Carcinoma: The Correlation Between Split Signal Pattern in FISH and Prognosis

Clinical and Pathological Heterogeneity of Four Common Fusion Subtypes in Xp11.2 Translocation Renal Cell Carcinoma

Diagnosis of adults Xp11.2 translocation renal cell carcinoma by immunohistochemistry and FISH assays: clinicopathological data from ethnic Chinese population

Renal Cell Carcinoma Associated with Xp11.2 Translocation/tfe3 Gene Fusions: Clinical Experience and Literature Review

Newly Designed Break-Apart and ASPL-TFE3 Dual-Fusion FISH Assay Are Useful in Diagnosing Xp11.2 Translocation Renal Cell Carcinoma and ASPL-TFE3 Renal Cell Carcinoma

[Application of Polyclonal Break-Apart Probes in the Diagnosis of Xp11.2 Translocation Renal Cell Carcinoma].

MP19-05 CLINICOPATHOLOGIC FEATURES OF XP11.2 TRANSLOCATION RENAL CELL CARCINOMA: CHINESE MULTI-INSTITUTIONAL ANALYSIS

[Clinical Features of Renal Cell Carcinoma Associated with Xp11.2 Translocation/tfe3 Gene Fusions-Single-center Study].

MED15-TFE3 Renal Cell Carcinoma: a Xp11 Translocation Renal Cell Carcinoma Subtype With Distinct Clinicopathological Features and Superior Prognosis

Genomic Alterations and Tumor Mutational Features of Chinese Xp11.2 Translocation Renal Cell Carcinoma Patients

Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis.

Xp11 Translocation Renal Cell Carcinoma In Adults: A Clinicopathological And Comparative Genomic Hybridization Study

TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.

Dynamic Contrast-Enhanced CT Characterization of Xp11.2 Translocation/TFE3 Gene Fusions Versus Papillary Renal Cell Carcinomas

Xp11.2 translocation renal cell carcinoma with NONO-TFE3 gene fusion: morphology, prognosis, and potential pitfall in detecting TFE3 gene rearrangement

Postoperative recurrence of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.

Clinicopathological Features and Prognosis of TFE3-positive Renal Cell Carcinoma

Therapeutic Strategies and Predictive Models for Xp11.2 Translocation/tfe3 Gene Fusion Renal Cell Carcinoma in Adults Based on Data of Two Chinese Medical Centers.

Imaging features of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions: comparison with chromophobe renal cell carcinoma

Are Tumor-Associated Micro-Angiogenesis and Lymphangiogenesis Considered As the Novel Prognostic Factors for Patients with Xp11.2 Translocation Renal Cell Carcinoma?

Detection of the ASPL-TFE 3 and PRCC-TFE 3 gene fusion in paraffin-embedded Xp 11 translocation renal cell carcinomas